Absence of Longer Reorientation Times in Patients Undergoing Electroconvulsive Therapy and Concomitant Treatment with Lithium

OBJECTIVE: Lithium is a drug of choice in the treatment of bipolar disorder and refractory depressive disorders. However, previous research suggests lithium has a negative cognitive impact in recovery from electroconvulsive therapy (ECT) and a higher risk of delirium, so patients are often required...

Descripción completa

Detalles Bibliográficos
Autores principales: Martins-Ascencao, Ricardo, Rodrigues-Silva, Nuno, Trovão, Nuno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553532/
https://www.ncbi.nlm.nih.gov/pubmed/34690124
http://dx.doi.org/10.9758/cpn.2021.19.4.695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553532/
https://www.ncbi.nlm.nih.gov/pubmed/34690124
http://dx.doi.org/10.9758/cpn.2021.19.4.695

Ejemplares similares